Literature DB >> 7743999

Interleukin-1 beta converting enzyme requires oligomerization for activity of processed forms in vivo.

Y Gu1, J Wu, C Faucheu, J L Lalanne, A Diu, D J Livingston, M S Su.   

Abstract

Interleukin-1 beta converting enzyme (ICE) is composed of 10' (p10) and 20 kDa (p20) subunits, which are derived from a common 45 kDa precursor. Recent crystallographic studies have shown that ICE exists as a tetramer (p20/p10)2 in the crystal lattice. We provide evidence that the p10 and p20 subunits of ICE associate as oligomers in transfected COS cells. Using intragenic complementation, we show that the activity of a p10/p10 interface mutant defective in autoprocessing can be restored by co-expression with active site ICE mutants. Different active site mutants can also complement each other by oligomerization to form active ICE. These studies indicate that ICE precursor polypeptides may associate in different quaternary structures and that oligomerization is required for autoprocessing. Furthermore, integenic complementation of active site mutants of ICE and an ICE homolog restores autoprocessing activity, suggesting that hetero-oligomerization occurs between ICE homologs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743999      PMCID: PMC398291          DOI: 10.1002/j.1460-2075.1995.tb07184.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  28 in total

1.  Domain swapping: entangling alliances between proteins.

Authors:  M J Bennett; S Choe; D Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

Review 2.  Checkpoints of dueling dimers foil death wishes.

Authors:  Z N Oltvai; S J Korsmeyer
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

3.  Structure and mechanism of interleukin-1 beta converting enzyme.

Authors:  K P Wilson; J A Black; J A Thomson; E E Kim; J P Griffith; M A Navia; M A Murcko; S P Chambers; R A Aldape; S A Raybuck
Journal:  Nature       Date:  1994-07-28       Impact factor: 49.962

4.  Prevention of vertebrate neuronal death by the crmA gene.

Authors:  V Gagliardini; P A Fernandez; R K Lee; H C Drexler; R J Rotello; M C Fishman; J Yuan
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

5.  Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death.

Authors:  L Wang; M Miura; L Bergeron; H Zhu; J Yuan
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

6.  Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2.

Authors:  D L Vaux; I L Weissman; S K Kim
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

7.  Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer.

Authors:  N P Walker; R V Talanian; K D Brady; L C Dang; N J Bump; C R Ferenz; S Franklin; T Ghayur; M C Hackett; L D Hammill
Journal:  Cell       Date:  1994-07-29       Impact factor: 41.582

8.  Interleukin 1 beta (IL-1 beta) processing in murine macrophages requires a structurally conserved homologue of human IL-1 beta converting enzyme.

Authors:  S M Molineaux; F J Casano; A M Rolando; E P Peterson; G Limjuco; J Chin; P R Griffin; J R Calaycay; G J Ding; T T Yamin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor.

Authors:  J M Ayala; T T Yamin; L A Egger; J Chin; M J Kostura; D K Miller
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

10.  Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.

Authors:  M Miura; H Zhu; R Rotello; E A Hartwieg; J Yuan
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  32 in total

1.  The structure of procaspase 6 is similar to that of active mature caspase 6.

Authors:  Byoung Heon Kang; Eunsil Ko; Oh-Keun Kwon; Kwan Yong Choi
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

Review 2.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

3.  Increased apoptosis of CD20+ IgA + B cells is the basis for IgA deficiency: the molecular mechanism for correction in vitro by IL-10 and CD40L.

Authors:  Zaheed Husain; Nichol Holodick; Caitlin Day; Irma Szymanski; Chester A Alper
Journal:  J Clin Immunol       Date:  2006-04-26       Impact factor: 8.317

Review 4.  Apoptotic cascades as possible targets for inhibiting cell death in Huntington's disease.

Authors:  Lindsay R Pattison; Mark R Kotter; Dean Fraga; Raphael M Bonelli
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

5.  Independently cloned halves of cytomegalovirus assemblin, An and Ac, can restore proteolytic activity to assemblin mutants by intermolecular complementation.

Authors:  M R Hall; W Gibson
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

Authors:  J P Medema; C Scaffidi; F C Kischkel; A Shevchenko; M Mann; P H Krammer; M E Peter
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

7.  pH effects on the stability and dimerization of procaspase-3.

Authors:  Kakoli Bose; A Clay Clark
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

Review 8.  Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion.

Authors:  Gunnar N Schroeder; Hubert Hilbi
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

9.  Overexpression of Caspase-1 in adenocarcinoma of pancreas and chronic pancreatitis.

Authors:  Yin-Mo Yang; Marco Ramadani; Yan-Ting Huang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  An uncleavable procaspase-3 mutant has a lower catalytic efficiency but an active site similar to that of mature caspase-3.

Authors:  Kakoli Bose; Cristina Pop; Brett Feeney; A Clay Clark
Journal:  Biochemistry       Date:  2003-10-28       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.